Q1 2025 Holdings
Filed 2025-05-15 | 83 holdings | $352.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $2.8M | 212,001 | 0.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.9M | 169,996 | 0.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.0M | 443,998 | 0.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.1M | 463,368 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.1M | 94,200 | 0.9% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.1M | 11,900 | 0.9% |
| Inogen Inc(INGN) | COM | 45780L104 | $3.3M | 458,065 | 0.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.3M | 130,175 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.0M | 183,140 | 1.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.2M | 558,255 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.5M | 65,552 | 1.3% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $4.7M | $4,000,000 | 1.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.9M | 625,126 | 1.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.9M | 309,200 | 1.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $5.3M | 220,235 | 1.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $5.4M | 492,515 | 1.5% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $5.6M | 294,208 | 1.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $5.8M | 731,363 | 1.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.7M | 544,502 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.9M | 71,615 | 2.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.7M | 752,359 | 2.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.2M | 273,739 | 2.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $9.7M | 589,330 | 2.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.5M | 80,398 | 3.6% |
| Axogen Inc(AXGN) | COM | 05463X106 | $12.6M | 680,782 | 3.6% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.1M | 102,500 | 3.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $13.5M | 152,263 | 3.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.0M | 398,100 | 4.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $19.1M | 592,273 | 5.4% |
| Merus N V | COM | N5749R100 | $19.4M | 461,804 | 5.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $23.2M | 656,176 | 6.6% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $24.1M | 13,680,554 | 6.8% |
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $32.8M | 404,505 | 9.3% |